AHA blog: PhRMA report misleads on drug costs
Instead of attacking hospitals and health systems caring for patients during the COVID-19 pandemic, PhRMA should instead focus on lowering the costs of drugs for Americans, writes AHA Executive Vice President Tom Nickels.
Related News Articles
Perspective
1.5 million people. That’s the approximate number of people that hospitals and health systems have treated for COVID-19 since the pandemic began. To put that…
Perspective
For the last few weeks, we’ve used this space to highlight the need for the next COVID-19 relief package to provide hospitals and health systems with…
Headline
A new analysis prepared by Kaufman, Hall & Associates, LLC and released today by the AHA shows that total hospital revenue in 2021 could be down between $…
Headline
State and regional hospital associations today filed friend-of-the-court briefs supporting AHA’s request for the U.S. Supreme Court to review two circuit court…
Headline
A new resource from the American Society for Health Care Engineering and Naval Medicine Readiness and Training Command summarizes recommended ventilation…
Perspective
Congress returns to Washington, D.C., next week, and its top focus will be passing President Biden’s $1.9 trillion COVID-19 relief legislation.
The House is…